Zinc finger protein 139 expression in gastric cancer and its clinical significance

Table 1 Zinc finger protein 139 expression in 108 gastric carcinoma patients according to clinicopathologic features

Clinical feature	Zinc finger protein 139		P value
	Positive (n)	Negative (n)
Sex			0.655
Male	53	25
Female	19	11
Age (yr)			0.539
≥ 60	43	19
< 60	29	17
Tumor differentiation			0.039
High/moderate	39	27
Poor/undifferentiated	33	9
Depth of invasion			0.008
T1/T2	8	12
T3/T4	64	24
Lymphatic metastasis			0.005
Positive	53	16
Negative	19	20
Nerve or blood vessel invasion			0.033
Invaded	29	7
Not invaded	43	29
Tumor-node-metastasis stage			0.002
I-II	21	22
III	51	14

Table 2 Results of Cox risk analysis model of gastric cancer

	B	SE	Wald	df	P value	Exp(B)	95%CI for Exp(B)
							Lower	Upper
ZNF139 expression	0.822	0.353	5.414	1	0.02	2.276	1.138	4.551
Lymphatic metastasis	1.396	0.645	4.679	1	0.031	4.038	1.14	14.301
Neurovascular invasion	0.573	0.257	4.965	1	0.026	1.774	1.072	2.939
TNM stage	1.155	0.554	4.351	1	0.037	3.175	1.072	9.401

TNM: Tumor node metastasis; ZNF139: Zinc finger protein 139.